BN82002 is a synthetic pan-CDC25 inhibitor that reduces proliferation of the carcinoma cell lines Mia PaCa-2, DU-145, U-87 MG, LNCaP, HT-29, and U2OS, with 96-h IC50 values in the range 7.2–32.6 μM (15). The gene discussed is CDC25C; the disease is carcinoma.